SAN FRANCISCO--(BUSINESS WIRE)--California Life Sciences Association (CLSA), the state’s largest and most influential life sciences advocacy and business leadership organization representing California’s leading life sciences innovators, today announced winners of the 2016 Pantheon DiNA Awards, a distinguished awards program honoring innovation and excellence within California’s life sciences sector.
The annual program, now in its 13th year, brings together more than 600 industry pioneers – including innovators, investors and educators – and recognizes the achievements and excellence of those dedicated to enhancing California’s life sciences community. This year’s winners will be honored at the 2016 Pantheon Awards ceremony on Dec. 2 at the Westin St. Francis in San Francisco.
“California’s premier life sciences community continues to blossom and grow to new heights thanks to our innovators and entrepreneurs statewide who are hard at work producing the most advanced medicines, diagnostics and technologies in the world,” said Sara Radcliffe, President and CEO of California Life Sciences Association (CLSA). “At CLSA’s 2016 Pantheon DiNA Awards ceremony on Dec. 2, we will celebrate the great leaders, both individuals and companies, that have made extraordinary contributions to the California life sciences community this year.”
Winners of the 2016 Pantheon DiNA winners include, sorted by award category:
- Life Sciences Leadership Award: David Pyott, former chairman and CEO, Allergan and Scott Morrison, former U.S. Life Sciences leader, Ernst & Young
- Outstanding Company: Relypsa, Inc.
- Outstanding Partnering: Five Prime Therapeutics, Inc.
- Outstanding Product, Therapeutic: ACADIA Pharmaceuticals, NUPLAZID™ (pimavanserin)
- Outstanding Product, Medical Device/Diagnostic: Edwards Lifesciences Corporation, SAPIEN 3 Transcatheter Heart Valve
- Rising Star Award: PaxVax Corporation
- Biotechnology Educator Award: Elizabeth Schar, RSI program founder, Ravenswood Science Initiative
Ticketing, event and sponsorship information is available at www.clsapantheon.org. The event will commence with a reception at 5:30 p.m. PT, followed by a presentation and dinner at 7 p.m. PT. Members of the press may obtain complimentary registration by RSVP’ing to Will Zasadny (Wzasadny@CALifeSciences.org or 619-961-8848).
To learn more about CLSA and its offerings, please visit: www.califesciences.org.
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
